Status:
COMPLETED
Perioperative Immunonutrition for Patients Undergoing CRS and HIPEC
Lead Sponsor:
National Cancer Centre, Singapore
Conditions:
Peritoneal Metastases
Eligibility:
All Genders
21+ years
Phase:
NA
Brief Summary
Patients with peritoneal disease commonly present with symptoms of abdominal distension and subacute intestinal obstruction. This results in poor oral intake leading to these patients often presenting...
Eligibility Criteria
Inclusion
- All patients planned for CRS and HIPEC, with sufficient time (5 to 7 days) prior to surgery for start of nutritional supplements are eligible
- All patients must be able to provide informed consent
- There are no restrictions to use of contraception
Exclusion
- Patients who are not able to provide informed consent will be excluded.
- Patients with a diagnosis of diabetes mellitus will be excluded.
- Patients not fit for surgery or those who undergo surgery under emergency situations will be excluded.
- Patients who have intestinal obstruction and not able to consume the nutritional supplements orally will be excluded.
Key Trial Info
Start Date :
April 23 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 22 2019
Estimated Enrollment :
70 Patients enrolled
Trial Details
Trial ID
NCT03430128
Start Date
April 23 2017
End Date
January 22 2019
Last Update
September 20 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Cancer Centre Singapore
Singapore, Singapore, 169610